跳至主要内容
临床试验/ISRCTN72251782
ISRCTN72251782已完成不适用

Randomised study to compare aspirin versus hydroxyurea/aspirin in 'intermediate risk' primary thrombocythaemia (PT) and hydroxyurea/aspirin versus anagrelide/aspirin in 'high risk' primary thrombocythaemia

Medical Research Council (MRC) (UK)0 个研究点目标入组 1,600 人开始时间: 2000年10月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients over 18 years of age meeting diagnostic criteria of PT

排除标准

  • Severe heart disease excludes patients from the 'high risk' study.

研究者

发起方
Medical Research Council (MRC) (UK)

相似试验

进行中(未招募)
1 期
A randomised trial to compare ASPIRIN versus HYDROXYUREA/ASPIRIN in 'intermediate risk' primary thrombocythaemia and ASPIRIN only with observation in 'Low risk' primary thrombocythaemia. - PT1Intermediate risk and low risk primary thrombocythaemia.MedDRA version: 8.1Level: PTClassification code 10036735Term: Primary thrombocytopenia
EUCTR2004-000245-38-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,459
已完成
不适用
Primary Thrombocythaemia 1 TrialThrombocythemiaMyeloproliferative Disorder
NCT00175838University of Cambridge1,398
已完成
不适用
Efficacy and safety of prolonged use of aspirin or rivaroxaban after surgery for hip fracturesPrevention of venous thromboembolism after hip fracture surgeryCirculatory System
ISRCTN76129839Department of Orthopedic Surgery, West China Hospital, Sichuan University390
Unknown
不适用
Comparison between the roles of low dose aspirin and folic acid in preventing preeclampsia among high risk women screened by uterine artery Doppler atPregnancy and ChildbirthPreeclampsia
PACTR201503001054393Cairo University210
进行中(未招募)
1 期
Add-on to antipsychotics in the treatment of schizophreniaschizophrenia and schizoaffective disorder.MedDRA version: 17.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 17.0Level: PTClassification code 10039621Term: Schizoaffective disorderSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2014-000757-36-ROClinirx Tangent Research160